FDA inspection
Genesis Biologics, Inc.: FDA inspection ending Jun 26, 2018
FDA inspection 1060113 · No Action Indicated (NAI) · Irvine, CA
Key facts
| Inspection ID | 1060113 |
|---|---|
| Firm | Genesis Biologics, Inc. |
| FEI number | 3008066433 |
| Address | 16782 Von Karman Ave Ste 17 |
| City | Irvine |
| State | CA |
| ZIP | 92614 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Jun 26, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data